"A blockbuster deal between Bayer and Monsanto appears to be moving ahead.

On Monday, the US Department of Justice approved the German pharmaceutical and chemical group's bid to buy the US seed giant for more than $60 billion, The Wall Street Journal reported. Bayer agreed to sell off additional assets to alleviate anti-trust concerns.

The two companies first announced the potential deal in September 2016, saying the move would boost agriculture research and innovation. "

Dana Varinsky reports for Business Insider April 9, 2018. [2]

SEE ALSO:

"Bayer-Monsanto Deal Reportedly Gets Justice Department's OK, Clearing The Last Big Regulatory Hurdle" (Bloomberg) [3]